INTRODUCTION AND OBJECTIVES: To analyze the prevalence and control of hypertensive patients with associated cardiac diseases in Spain. METHODS: All the 32,051 outpatients seen the same day by 1,159 primary physicians (79%) and cardiologists (21%) were prospectively included in a database including history of cardiac disease (heart failure, coronary disease or atrial fibrillation), casual blood pressure and ongoing treatments. RESULTS: Hypertension was present in 33% of the whole group and 19% had both hypertension and a cardiac disease. Hypertension was present in 77% of the patients with heart failure, in 66% of those with coronary diseases and in 66% with atrial fibrillation. Less than 60% of the hypertensive patients with heart failure were treated with an angiotensin or a converting enzyme inhibitor. Thirty-two percent of the hypertensive patients with coronary disease received a betablocker and 25% of the hypertensive patients with atrial fibrillation were on oral anticoagulation. Less than 20% of the patients with hypertension and cardiac disease had blood pressure levels under 130/85 mmHg as recommended by international guidelines. Patients seen by primary care physicians were found to be slightly better treated than those under cardiologists' care. CONCLUSIONS: High blood pressure is associated with heart failure, coronary disease and atrial fibrillation in a high percentage of patients. The blood pressure levels recommended by current guidelines for cardiac hypertensives were attained in less than 20% of the cases. The control of blood pressure in these high risk hypertensive patients was low and the use of appropriate pharmacological treatment was poor.
INTRODUCTION AND OBJECTIVES: To analyze the prevalence and control of hypertensivepatients with associated cardiac diseases in Spain. METHODS: All the 32,051 outpatients seen the same day by 1,159 primary physicians (79%) and cardiologists (21%) were prospectively included in a database including history of cardiac disease (heart failure, coronary disease or atrial fibrillation), casual blood pressure and ongoing treatments. RESULTS:Hypertension was present in 33% of the whole group and 19% had both hypertension and a cardiac disease. Hypertension was present in 77% of the patients with heart failure, in 66% of those with coronary diseases and in 66% with atrial fibrillation. Less than 60% of the hypertensivepatients with heart failure were treated with an angiotensin or a converting enzyme inhibitor. Thirty-two percent of the hypertensivepatients with coronary disease received a betablocker and 25% of the hypertensivepatients with atrial fibrillation were on oral anticoagulation. Less than 20% of the patients with hypertension and cardiac disease had blood pressure levels under 130/85 mmHg as recommended by international guidelines. Patients seen by primary care physicians were found to be slightly better treated than those under cardiologists' care. CONCLUSIONS: High blood pressure is associated with heart failure, coronary disease and atrial fibrillation in a high percentage of patients. The blood pressure levels recommended by current guidelines for cardiac hypertensives were attained in less than 20% of the cases. The control of blood pressure in these high risk hypertensivepatients was low and the use of appropriate pharmacological treatment was poor.
Authors: Alberto Cordero; Vicente Bertomeu-Martínez; Pilar Mazón; Lorenzo Fácila; Juan Cosín; Vicente Bertomeu-González; Moisés Rodriguez; Eva Andrés; Enrique Galve; Iñaki Lekuona; Jose R González-Juanatey Journal: World J Cardiol Date: 2013-08-26
Authors: A Varela-Roman; J R Gonzalez-Juanatey; P Basante; R Trillo; J Garcia-Seara; J L Martinez-Sande; F Gude Journal: Heart Date: 2002-09 Impact factor: 5.994
Authors: Joan-Josep Cabré; Francisco Martín; Bernardo Costa; Josep L Piñol; Josep L Llor; Yolanda Ortega; Josep Basora; Marta Baldrich; Rosa Solà; Jordi Daniel; Josep Ma Hernández; Judit Saumell; Jordi Bladé; Ramon Sagarra; Teresa Basora; Dolors Montañés; Joan L Frigola; Angel Donado-Mazarrón; Maria Teresa García-Vidal; Isabel Sánchez-Oro; Josep M de Magriñà; Ana Urbaneja; Francisco Barrio; Jesús Vizcaíno; Josep M Sabaté; Irene Pascual; Vanesa Revuelta Journal: BMC Public Health Date: 2008-07-22 Impact factor: 3.295